Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Invitae Corp NVTAQ

Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services, digital health solutions, and health data services that support a lifetime of patient care and improved outcomes. It offers genetic testing across multiple clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases and pharmacogenomics. It applies... see more

Recent & Breaking News (GREY:NVTAQ)

Invitae Sees Increase in Utilization of Its Inherited Prostate Cancer Genetic Tests

Business Wire December 14, 2016

Invitae and TME Research Announce Landmark New Study to Evaluate Universal Genetic Testing of Breast Cancer Patients

Business Wire December 8, 2016

Invitae Adds Two Genes, Offers Faster Turnaround Time for Its Breast Cancer STAT Panel

Business Wire December 7, 2016

Invitae to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum

Business Wire November 17, 2016

Invitae Announces Pricing of Public Offering of Common Stock

Business Wire November 17, 2016

12 Biggest Mid-Day Losers For Wednesday

Benzinga.com  November 16, 2016

Mid-Day Market Update: Dow Falls 75 Points; Shipping Stocks Spike Higher

Benzinga.com  November 16, 2016

Mid-Morning Market Update: Markets Mostly Lower; Target Q3 Profit Beats Views

Benzinga.com  November 16, 2016

Invitae Announces Proposed Public Offering of Common Stock

Business Wire November 15, 2016

Invitae Announces Third Quarter 2016 Financial Results, Secures Contracts With Top Five Largest Payers, and Grows Volume More Than 200% Year-Over-Year

Business Wire November 7, 2016

Invitae to Announce Third Quarter 2016 Financial Results and Host Conference Call on November 7, 2016

Business Wire October 24, 2016

Invitae Announces Multiple Scientific Presentations and Posters to Be Presented at the American Society of Human Genetics 2016 Annual Meeting

Business Wire October 19, 2016

Invitae Announces Collaboration With Helix to Build Applications for Health and Wellness

Business Wire October 18, 2016

Invitae Announces Final Medicare Pricing Set at $925 for Hereditary Breast Cancer-Related Disorders Under New Billing Process

Business Wire October 3, 2016

Genetic Counselors Recognized by Patients, Peers for Excellence in Patient Care

Business Wire September 30, 2016

Invitae Presenting Research on Genetic Test Panels, Increasing Access to Genetic Counseling at the National Society of Genetic Counselors 35th Annual Education Conference

Business Wire September 28, 2016

Invitae Announces Major Expansion of Its Neurology and Cardiology Test Offerings

Business Wire August 15, 2016

Invitae Announces Second Quarter 2016 Financial Results, Secures Contract with a National Payer and Expands Its Network of Regional Private Payers

Business Wire August 8, 2016

Invitae to Present at the Canaccord Genuity 36th Annual Growth Conference

Business Wire July 28, 2016

Invitae to Announce Second Quarter 2016 Financial Results and Host Conference Call on August 8, 2016

Business Wire July 25, 2016